CX-5461, soluble in DMSO and warmed ethanol and insoluble in water, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis. It targets the A375, HCT-116, MIA PaCa-2, and Pol I-driven transcription of rRNA (HCT-116, A375, MIA PaCa-2 cells).
Molecular Weight
513.6
Molecular Formula
C27H27N7O2S
Targets
A375: 58 nM (ED50); HCT-116: 167 nM (ED50); MIA PaCa-2: 74 nM (ED50); Pol I-driven transcription of rRNA (HCT-116, A375, MIA PaCa-2 cells): 142 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
CX-5461 is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of cancer, especially after cancer stem cells have been sensitized to chemotherapy.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
